(Q35675045)

English

Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system

scientific article published on January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

0 references

anti-retroviral agent

0 references

2

object named as

Steven G Deeks

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Richard W Price

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Journal of NeuroVirology

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

10 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

44-51

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

https://scigraph.springernature.com/pub.10.1080/13550280490268223

0 references

Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structured treatment interruptions for the management of HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrospinal fluid response to structured treatment interruption after virological failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection?

1 reference

https://pubmed.ncbi.nlm.nih.gov/14982739

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1080/13550280490268223

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35675045&oldid=1583439253"